ARCHIVES

Drugs and Targets: Cyramza approved in metastatic stomach cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 42 | November 7, 2014

Download PDF Visit The Full Archive

Related Articles

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

NCI RFA Available: Minority-Based CCOPS

August 15, 1997

NCAB, DRCCA Board Asked To Consider Dripping All Staff Investigator Salary Support From Core

October 17, 1980

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

BMS Settles Charges Of Obstructing Generics

March 14, 2003

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014